UNITED THERAPEUTICS Corp financial data

Symbol
UTHR on Nasdaq
Location
Silver Spring, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 635% % 42%
Quick Ratio 29% % 74%
Debt-to-equity 12% % -34%
Return On Equity 19% % -4.8%
Return On Assets 17% % 0.19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43,827,686 shares -2.8%
Common Stock, Shares, Outstanding 43,643,165 shares -2.6%
Entity Public Float $11,233,042,523 USD -7.6%
Common Stock, Value, Issued $800,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 44,300,000 shares -2%
Weighted Average Number of Shares Outstanding, Diluted 47,900,000 shares -1.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,182,700,000 USD 11%
Research and Development Expense $550,000,000 USD 14%
Costs and Expenses $1,690,200,000 USD 13%
Operating Income (Loss) $1,492,500,000 USD 8.4%
Nonoperating Income (Expense) $221,400,000 USD 37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,713,900,000 USD 11%
Income Tax Expense (Benefit) $379,200,000 USD 10%
Net Income (Loss) Attributable to Parent $1,334,700,000 USD 12%
Earnings Per Share, Basic 30.13 USD/shares 14%
Earnings Per Share, Diluted 27.86 USD/shares 13%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,557,100,000 USD -8.3%
Marketable Securities, Current $1,363,200,000 USD -13%
Accounts Receivable, after Allowance for Credit Loss, Current $350,200,000 USD 25%
Inventory, Net $183,100,000 USD 16%
Other Assets, Current $248,900,000 USD 47%
Assets, Current $3,702,500,000 USD -4.4%
Deferred Income Tax Assets, Net $357,700,000 USD -22%
Property, Plant and Equipment, Net $1,729,700,000 USD 42%
Goodwill $32,300,000 USD 0%
Other Assets, Noncurrent $196,900,000 USD -11%
Assets $7,880,000,000 USD 7%
Accounts Payable, Current $7,100,000 USD 18%
Employee-related Liabilities, Current $105,100,000 USD 12%
Accrued Liabilities, Current $480,900,000 USD 42%
Liabilities, Current $560,600,000 USD -24%
Other Liabilities, Noncurrent $223,200,000 USD 23%
Liabilities $783,800,000 USD -15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $900,000 USD
Retained Earnings (Accumulated Deficit) $8,556,900,000 USD 18%
Stockholders' Equity Attributable to Parent $7,096,200,000 USD 10%
Liabilities and Equity $7,880,000,000 USD 7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $461,200,000 USD 22%
Net Cash Provided by (Used in) Financing Activities $93,800,000 USD 91%
Net Cash Provided by (Used in) Investing Activities $164,700,000 USD -122%
Common Stock, Shares Authorized 245,000,000 shares 0%
Common Stock, Shares, Issued 76,452,253 shares 1.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $202,700,000 USD 363%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,557,100,000 USD -8.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,400,000 USD -57%
Deferred Tax Assets, Valuation Allowance $35,600,000 USD 18%
Deferred Tax Assets, Gross $482,400,000 USD -14%
Depreciation $19,600,000 USD 32%
Payments to Acquire Property, Plant, and Equipment $74,900,000 USD 96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,339,000,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid $37,600,000 USD -2.6%
Property, Plant and Equipment, Gross $2,297,500,000 USD 34%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,200,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,300,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,900,000 USD 13%
Deferred Tax Assets, Operating Loss Carryforwards $22,200,000 USD 12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $27,000,000 USD 38%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,100,000 USD 5.2%
Depreciation, Depletion and Amortization $19,800,000 USD 32%
Deferred Tax Assets, Net of Valuation Allowance $446,800,000 USD -16%
Share-based Payment Arrangement, Expense $147,700,000 USD 2.6%
Interest Expense $58,800,000 USD 42%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%